AFP and hepatocellular carcinoma: Compared with those of patients carrying the rs1169310-CC allele, the average serum AFP levels of HCC patients carrying the TT allele and CT+TT allele were lower by 94.0% (P = 0.001) and 73.4% (P < 0.001), respectively.